Single-gene autoimmunity: APS-1 (AIRE), IPEX, ALPS, CTLA-4
- Topic
A few children inherit one broken 'brake' gene and develop autoimmunity in many organs early in life; each disease shows which brake failed.
What it is
Most autoimmune diseases come from many genes and the environment, but a few are caused by a single gene, each disabling one tolerance mechanism. Loss of AIRE breaks thymic deletion (APS-1), loss of FOXP3 removes regulatory T cells (IPEX), defects in the Fas pathway prevent deletion of activated lymphocytes (ALPS), and reduced CTLA-4 removes a key T-cell brake. They teach the mechanisms of tolerance and are treated more and more with targeted drugs.
Key facts
- Double-negative T cells (TCRαβ⁺, CD4⁻ CD8⁻) are a laboratory hallmark of ALPS.
- Candidiasis in APS-1 comes from autoantibodies that neutralise IL-17 and IL-22, the antifungal cytokines.
- APS-1 is more frequent in some founder populations (for example Finnish and Sardinian).
- Abatacept (CTLA-4–Ig) replaces the missing brake in CTLA-4 and LRBA deficiency.
Step by step
- In the thymus, AIRE switches on tissue proteins (insulin, parathyroid, adrenal) so self-reactive T cells see them and die.
- AIRE lost → those T cells escape → attack on parathyroid and adrenal, plus anti-IL-17/IL-22 antibodies → candidiasis (APS-1).
- In the periphery, FOXP3 Tregs suppress escaped clones; FOXP3 lost → no Tregs → gut, pancreas and skin attacked in infancy (IPEX).
- Tregs use CTLA-4 to strip CD80/86 from APCs; too little CTLA-4 (or LRBA) → T cells overactivate, infiltrate organs.
- After a response, FAS triggers apoptosis of activated lymphocytes; FAS lost → cells pile up → big nodes, spleen, cytopenias (ALPS).
Monogenic autoimmune diseases
| Disease | Gene and inheritance | Tolerance step lost | Main features |
|---|---|---|---|
| APS-1 (APECED) | AIRE, autosomal recessive | Thymic expression of tissue antigens → central deletion | Chronic mucocutaneous candidiasis, hypoparathyroidism, adrenal insufficiency; autoantibodies to IL-17 and IL-22 |
| IPEX | FOXP3, X-linked | Regulatory T cells | Boys in infancy: severe enteropathy with diarrhoea, early type 1 diabetes, eczema |
| ALPS | FAS (most), FASLG, CASP10; usually autosomal dominant | Apoptosis of activated lymphocytes | Lymphadenopathy, splenomegaly, autoimmune cytopenias, raised double-negative T cells, lymphoma risk |
| CTLA-4 haploinsufficiency | CTLA4, autosomal dominant, incomplete penetrance | Treg suppression via CTLA-4 | Enteropathy, cytopenias, lymphocytic infiltration of organs, low antibodies |
| LRBA deficiency | LRBA, autosomal recessive | Recycling of CTLA-4 to the cell surface | Similar to CTLA-4 haploinsufficiency |
| Early complement deficiency | C1q, C2, C4 | Clearance of apoptotic cells and immune complexes | Lupus-like disease |
Clinical notes
- Suspect a monogenic cause when autoimmunity starts in infancy, involves several organs or comes with immunodeficiency.
- IPEX is treated with immunosuppression and haematopoietic stem cell transplant.
- Genetic testing guides targeted therapy (abatacept, JAK inhibitors for STAT gain-of-function disorders, mTOR inhibitors in ALPS).
Common traps
- Candidiasis in APS-1 means a T-cell immunodeficiency: it comes from autoantibodies that neutralise IL-17 and IL-22.
- IPEX can affect girls as well as boys: FOXP3 is X-linked, so it is almost always boys.
- ALPS lymphadenopathy is lymphoma until proven otherwise: it is usually benign accumulation, though lymphoma risk is raised.
- Monogenic autoimmunity behaves like common autoimmunity: suspect it when onset is in infancy, many organs or with immunodeficiency.
Test yourself
Think of the answer, then tap the question to see it.
A child has chronic oral candidiasis, low calcium with tetany and later adrenal insufficiency. Which gene is affected and which tolerance step failed?
AIRE (APS-1): tissue antigens are not shown in the thymus, so self-reactive T cells are not deleted.
A boy has severe diarrhoea, type 1 diabetes and eczema in the first months of life. Which gene is likely affected?
FOXP3, causing IPEX syndrome with absent or defective regulatory T cells.
Why do patients with ALPS have huge lymph nodes and spleen without infection?
Defective FAS-mediated apoptosis means activated lymphocytes are not removed after responses, so they accumulate; double-negative T cells rise.
Why is abatacept a logical treatment for CTLA-4 haploinsufficiency or LRBA deficiency?
Abatacept is CTLA-4–Ig: it replaces the missing brake by blocking CD80/86 costimulation.
Connections
Microorganisms1
In Pharmacology1
Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.
Sources: AIRE gene (MedlinePlus Genetics, US National Library of Medicine, 2024); Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (MedlinePlus Genetics, US National Library of Medicine, 2024); Autoimmune lymphoproliferative syndrome (MedlinePlus Genetics, US National Library of Medicine, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
